ADDvise Group AB (publ) Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
ADDvise Group AB (publ) Stock Forecast and Price Target
According to esteemed experts, the average price target for ADDvise Group AB (publ) to reach this year is kr19.00, with a potential upside of approximately 36.69%. This prediction is based on a high estimate of kr19.00 and a low estimate of kr19.00. If you're not interested in ADDV A stock, you may be interested in its competitors.
36.69% Upside
ADDvise Group AB (publ) Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, ADDvise Group AB (publ)'s Price has fallen from kr0.66 to kr0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach kr36.25 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SEDANA Stock Forecast | Sedana Medical AB (publ) | Outperform |
7
|
kr22.15 | Buy/Sell | kr43.00 | 60.27% |
| STIL Stock Forecast | Stille AB |
0
|
kr201.00 | Buy/Sell | kr150.00 | 1.00% | |
| BIBB Stock Forecast | BiBBInstruments AB | - |
5
|
kr2.96 | Buy/Sell | kr0.00 | -100.00% |
| ICO Stock Forecast | Iconovo AB (publ) |
0
|
kr8.04 | Buy/Sell | kr37.50 | 161.19% | |
| NANEXA Stock Forecast | Nanexa AB (publ) |
0
|
kr0.69 | Buy/Sell | kr3.40 | 392.75% |
ADDvise Group AB (publ) Revenue Forecast for 2023 - 2025 - 2030
ADDvise Group AB (publ)'s Revenue has seen impressive growth In the last three years, rising from kr359.26M to kr1.38B – a growth of 283.79%. According to 0 analysts, ADDvise Group AB (publ)'s Revenue will fall by 34.97% in the next year, reaching kr896.63M. Professionals believe that By 2030, ADDvise Group AB (publ)'s Revenue will fall to kr937.03M – a 32.04% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GTAB B Stock Forecast | Glycorex Transplantation AB (p... | - |
0
|
kr1.00 | Buy/Sell | kr0.00 | -100.00% |
| ISAB Stock Forecast | Inhalation Sciences Sweden AB ... |
0
|
kr4.34 | Buy/Sell | kr17.00 | 280.18% | |
| HEMC Stock Forecast | Hemcheck Sweden AB (publ) | - |
4
|
kr0.18 | Buy/Sell | kr0.00 | -100.00% |
.jpg)
ADDvise Group AB (publ) EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, ADDvise Group AB (publ)'s EBITDA has seen an increase, rising from kr36.57M to kr395.60M. This represents a growth of 981.76%. Analysts predict that ADDvise Group AB (publ)'s EBITDA will increase in the upcoming year, reaching kr544.33M. This would represent an increase of 37.60%. Over the next seven years, experts predict that ADDvise Group AB (publ)'s EBITDA will grow at a rate of 146.46%.
ADDvise Group AB (publ) EBIT Forecast for 2023 - 2025 - 2030
ADDvise Group AB (publ)'s EBIT has seen growth In the last three years, going from kr28.40M to kr286.90M – a gain of 910.21% In the next year, analysts believe that EBIT will reach kr417.62M – an increase of 45.56%. For the next seven years, the forecast is forEBIT to grow by 168.04%.
ADDvise Group AB (publ) EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, ADDvise Group AB (publ)'s EPS has fallen from kr0.02 to kr0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach kr1.10 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)